WORCESTER, Mass. — Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today reported preliminary outcomes and trends from the ongoing Phase III pivotal study of Generex Oral-lyn, the Company’s proprietary oral insulin spray product.
WORCESTER, Mass.
A signing ceremony for a strategic partnership agreement between Tianjin International Joint Academy of Biotechnology and Medicine and Genzyme Corporation was held in the Tianjin Economic-Technological Development Area on 10 May.
QA Team Leader – Biotechnology – North West.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has received a new patent in the United States.
Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.